Shares of Apollo Hospitals Enterprises Ltd touched a new 52-week high of ₹7,918 on the NSE, before slightly easing to trade at ₹7,917, up 0.43% from its previous close. The rally comes on the back of robust quarterly and annual earnings that have strengthened investor sentiment.
Strong Quarterly Growth
For the quarter ending June 2025, Apollo Hospitals reported:
- Revenue: ₹5,842.10 crore (up from ₹5,085.60 crore in June 2024)
- Net Profit: ₹427.40 crore (vs ₹304 crore YoY)
- EPS: ₹30.10 (vs ₹21.23 YoY)
Impressive Annual Performance
In FY25 (ending March 2025), the company posted:
- Revenue: ₹21,794 crore (+14.35% YoY)
- Net Profit: ₹1,472.10 crore (+60.53% YoY)
- EPS: ₹100.56 (vs ₹62.50 in FY24)
The Return on Equity (ROE) improved to 17.60%, while the Operating Margin strengthened to 11.30%, reflecting better efficiency.
Dividend and Investor Sentiment
Apollo announced a final dividend of ₹10/share (200%) for FY25, following an interim dividend of ₹9/share (180%) in February 2025. The stock has seen bullish sentiment, supported by analyst upgrades and investor confidence in the company’s growth trajectory.
Outlook
With sustained earnings growth, expanding healthcare demand, and solid governance, Apollo Hospitals continues to remain a market favorite in the healthcare sector.
Disclaimer: The information provided is for general informational purposes only and should not be construed as financial or investment advice. Readers are advised to consult with a qualified financial advisor before making any investment decisions.
